HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Overcoming glucocorticoid resistances and improving antitumor therapies: lipid and polymers carriers.

AbstractPURPOSE:
To improve chemotherapy protocols of lymphoid malignancies, by using polymeric and lipid microparticles as controlled delivery systems of dexamethasone, part of all combined chemotherapy protocols for its strong-inducing effect on malignant lymphoblasts.
METHODS:
Polymeric microparticles were prepared by the oil-in-water-emulsion cosolvent evaporation method, andlipid microparticles by spray drying. Their cytotoxic effects on GC-sensitive PC12 cells and GC-resistant PC3 cells were characterized by cell proliferation and apoptosis assays.
RESULTS:
Both elaboration methods rendered optimal-sized microparticles for parenteral administration with high drug loading. In vitro assays showed sustained dexamethasone release from polymeric microparticles over a month, whereas 100% dexamethasone release from lipid microparticles was achieved within 24 h. Similar PC12 cell death to that obtained with dexamethasone solution administered every 48 h was achieved with dexamethasone polymeric microparticles in 26-days assays. Dexamethasone solution and loaded polymeric microparticles induced apoptosis around 15.8 and 19.9%, respectively, after 2 days of incubation. Lipid microparticles increased further apoptosis induction in PC12 cells and, unlike dexamethasone solution and polymeric microparticles, showed antiproliferative effects on PC3 cells.
CONCLUSIONS:
Dexamethasone polymeric microparticles constitute an alternative to current dexamethasone administration systems in combined chemotherapy, whereas dexamethasone lipid microparticles represent a potential tool to revert glucocorticoid resistance.
AuthorsC Martín-Sabroso, A J Moreno-Ortega, J Aparicio-Blanco, A I Fraguas-Sánchez, M F Cano-Abad, A I Torres-Suárez
JournalPharmaceutical research (Pharm Res) Vol. 32 Issue 3 Pg. 968-85 (Mar 2015) ISSN: 1573-904X [Electronic] United States
PMID25213776 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Drug Carriers
  • Lipids
  • Polymers
  • Dexamethasone
Topics
  • Adrenal Gland Neoplasms (pathology)
  • Animals
  • Antineoplastic Agents (chemistry, pharmacology)
  • Apoptosis (drug effects)
  • Cell Proliferation (drug effects)
  • Chemistry, Pharmaceutical
  • Dexamethasone (chemistry, pharmacology)
  • Dose-Response Relationship, Drug
  • Drug Carriers
  • Drug Resistance, Neoplasm
  • Kinetics
  • Lipids (chemistry)
  • PC12 Cells
  • Particle Size
  • Pheochromocytoma (pathology)
  • Polymers (chemistry)
  • Rats
  • Solubility
  • Technology, Pharmaceutical (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: